Compound ID | 1895
Class: Beta-lactam
| Agent Type: | Semisynthetic; Small molecule; Direct acting; |
| Spectrum of activity: | Gram-positive & Gram-negative |
| Mechanism of action: | Cell wall synthesis inhibitor. Binds to bacterial penicillin-binding proteins (PBP); PBP inhibitor |
| Target Pathogen: | Active against Gram-positive bacteria and against many Enterobacteriaceae and some anaerobes; it is less vulnerable to extended-spectrum beta-lactamases (ESBL) |
| Description: | Semisynthetic Cephalosporin (cephamycin), derived from Cephalosporin C |
| Year first mentioned: | 1972 |
| Highest development stage: | Approved by FDA |
| Development status: | Approved |
| External links: | |
| PubChem link: | https://pubchem.ncbi.nlm.nih.gov/compound/441199 |
| Guide to Pharmacology: | cefoxitin |
| Citation: | https://link.springer.com/article/10.1007/s10096-019-03701-0 |